- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/02 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 471/02
Total number of patents in this class: 518
10-year publication summary
|
22
|
10
|
18
|
31
|
19
|
34
|
35
|
33
|
25
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Corporation | 1060 |
17 |
| Merck Sharp & Dohme LLC | 3723 |
12 |
| Bristol-myers Squibb Company | 4812 |
10 |
| Merck Patent GmbH | 5663 |
8 |
| Merck Sharp & Dohme Corp. | 2184 |
7 |
| Boehringer Ingelheim International GmbH | 4510 |
7 |
| Cephalon LLC | 114 |
6 |
| Amgen Inc. | 4353 |
5 |
| Abbvie Inc. | 1842 |
5 |
| Vertex Pharmaceuticals Incorporated | 1601 |
5 |
| Northwestern University | 3512 |
5 |
| Incyte Holdings Corporation | 636 |
5 |
| Medshine Discovery Inc. | 592 |
5 |
| Tolremo Therapeutics AG | 25 |
5 |
| Novartis AG | 10345 |
4 |
| AstraZeneca AB | 2837 |
4 |
| Janssen Pharmaceutica N.V. | 3234 |
4 |
| Allergan, Inc. | 2208 |
4 |
| Takeda Pharmaceutical Company Limited | 2721 |
4 |
| BeiGene, Ltd. | 265 |
4 |
| Other owners | 392 |